If 2023 was the year weight-loss injections such as Ozempic or WeGovy took over Hollywood, then 2024 was the year they went global. What does that mean for Novo Nordisk, the Danish company making them? And can it live up to the hype?
Writer: Claudia Williams
Producer: Claudia Williams
Photography: Joe Mee
Executive producer: Rebecca Moore
Hosted on Acast. See acast.com/privacy for more information.
